GILD Form 144: Officer plans sale of 25,000 shares

GILD filed a Form 144 reporting proposed sales of specified common stock.

Rhea-AI Filing Summary

GILD filed a Form 144 reporting proposed sales of specified common stock. The notice lists a Stock Option Exercise of 25,000 shares dated 05/15/2026, 494 restricted shares dated 12/10/2024, and 2,506 performance shares dated 02/04/2025.

The filing also records sales by Johanna Mercier in the prior three months: 3,000 shares on 04/15/2026 ($422,880.00), 3,000 shares on 03/16/2026 ($432,690.00), and 28,000 shares on 02/17/2026 ($4,324,227.70).

Insights

Securities Attorney

Form 144 lists proposed disposals tied to an option exercise and prior sales by Johanna Mercier.

The submission documents a Stock Option Exercise of 25,000 shares scheduled 05/15/2026 alongside historical dispositions by Johanna Mercier totaling 34,000 shares across three dates with disclosed gross proceeds. This form functions as a notice under Rule 144.

Timing and cash‑flow treatment for the proposed sales are stated as transaction dates in the excerpt; any transfer mechanics or restrictions are not described in the provided excerpt.

Key Figures

Stock Option Exercise: 25,000 shares Restricted Stock: 494 shares Performance Shares: 2,506 shares +3 more

6 metrics

Stock Option Exercise 25,000 shares dated 05/15/2026

Restricted Stock 494 shares dated 12/10/2024

Performance Shares 2,506 shares dated 02/04/2025

Recent sale (Mercier) 28,000 shares sold 02/17/2026 for $4,324,227.70

Recent sale (Mercier) 3,000 shares sold 03/16/2026 for $432,690.00

Recent sale (Mercier) 3,000 shares sold 04/15/2026 for $422,880.00

Key Terms

Stock Option Exercise, Restricted Stock, Performance Shares

3 terms

Stock Option Exercise financial

"Common | 05/15/2026 | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock financial

"Common | 12/10/2024 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 02/04/2025 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GILD's Form 144 report?

It reports proposed sales of common stock including a 25,000-share option exercise dated 05/15/2026. The filing also lists 494 restricted shares (12/10/2024) and 2,506 performance shares (02/04/2025) as securities to be sold.

Which securities and quantities are listed for proposed sale in the filing?

The filing lists a Stock Option Exercise: 25,000 shares (05/15/2026), Restricted Stock: 494 shares (12/10/2024), and Performance Shares: 2,506 shares (02/04/2025). These items appear under 'Securities To Be Sold.'

Who sold shares during the past three months per the Form 144?

The filing shows dispositions by Johanna Mercier: 28,000 shares on 02/17/2026 for $4,324,227.70, 3,000 shares on 03/16/2026 for $432,690.00, and 3,000 shares on 04/15/2026 for $422,880.00.

Are sale proceeds or recipients specified in the excerpt?

The excerpt provides gross proceeds for recent sales by Johanna Mercier with specific dollar amounts for each transaction. The filing lists proceeds values for those past sales but does not elaborate further on proceeds allocation or recipients in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001782135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JOHANNA MERCIER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28000	3676197.75	1241569874	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2026	Stock Option Exercise	ISSUER			25000	05/15/2026	Cash
Common	12/10/2024	Restricted Stock	ISSUER			494	12/10/2024	Not Applicable
Common	02/04/2025	Performance Shares	ISSUER			2506	02/04/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	04/15/2026	3000	422880.00
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	03/16/2026	3000	432690.00
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	02/17/2026	28000	4324227.70

144: Remarks and Signature

Remarks
Date of Notice	05/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johanna Mercier
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)